A. Bialkowska et al., Oxidative DNA damage in fetal tissues after transplacental exposure to 3 '-azido-3 '-deoxythymidine (AZT), CARCINOGENE, 21(5), 2000, pp. 1059-1062
The nucleoside analogue 3'-azido-3'-deoxythymidine (AZT) has been used succ
essfully to reduce the incidence of transplacental and perinatal transmissi
on of the HIV virus. However, prolonged treatment with high doses of AZT is
utilized in this therapy, and AZT has been found to be a perinatal carcino
gen in mice, Any possible perinatal carcinogenic side effects in the human
can best be managed if the mechanism is understood. AZT targets mitochondri
a and might cause increased intracellular production of reactive oxygen spe
cies (ROS), We tested whether transplacental AZT may cause oxidative damage
in nuclear DNA of fetal tissues. CD-1 Swiss pregnant mice were treated wit
h the transplacental carcinogenesis regimen (25 mg/day AZT, for gestation d
ays 12-18) and tissues collected on the day of birth. Significant increases
in 8-oxo-2'-deoxyguanosine (8-oxo-dG) were found in the livers, a target t
issue for transplacental carcinogenesis, and in the kidneys. A nonsignifica
nt increase occurred in brain, with no change in lung. Tissues were also ob
tained from fetal patas monkeys (Erythrocebus patas), whose mothers had rec
eived 10 mg AZT/day during the last half of gestation. Although limited num
bers of samples were available, possible increases in 8-oxo-dG were noted,
relative to controls, for placenta and for fetal lung and brain (P = 0.055
for treatment-related increases in these tissues). These results suggest th
at an increase in reactive oxygen species could contribute to the mechanism
of transplacental carcinogenesis by AZT in mice, and that this may also oc
cur in primates.